Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long covid.

On May 20, U.S. Food and Drug Administration ( FDA) officials announced that Covid-19 vaccines will no longer be available to everyone. Instead, annual boosters will be limited to people ages 65 and ...

For groups younger than 65 or without specific chronic conditions, postmarketing trials will be needed to open access.

A new study from the Kennedy Krieger Institute is calling attention to an emerging mental health crisis among children with ...

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...

In a recent study, a research team from the Medical University of Vienna has gained new insights into post-COVID syndrome ...

A new study from Kennedy Krieger Institute is calling attention to an emerging mental health crisis among children with long COVID. Researchers found that nearly 40% of pediatric patients with long ...

Researchers looked at biomarkers in study participants and found that those complaining of brain fog had higher levels of an ...

In a recent study, a research team from the Medical University of Vienna has gained new insights into post-COVID syndrome ...

As public health systems strain and families like Jennifer’s wait for solutions, scientists at Johns Hopkins are working ...

Federal officials unveiled a rigorous regulatory approach to future COVID vaccines that could make it harder for many people ...

In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...